Finnish
BBS-Bioactive Bone Substitutes Plc, Company Announcement on 1 February 2021 at 3:35 pm (UTC +2:00)
MSc. (Tech)
Liisa Hukka from Talenom Plc. has been appointed chief financial officer (CFO) of BBS-Bioactive Bone Substitutes PlC (”BBS”, ”the Company”). Hukka will take up her position on 1 February, 2021, when the Company’s current CFO
Hannu Säynäjäkangas retires. Hukka works on BBS’ Management Team and reports to the CEO.
Hukka has extensive experience in industrial financial management in both international listed companies and domestic growth companies. She is specialized in financial management in transition and growth phases of companies. For the past 5 years, Hukka has worked as a financial administration consultant at Talenom. Prior to that, she worked as CFO at Nestor Cable and in various financial management and business support positions at the Dutch Draka Holding BV Group. Hukka holds M.Sc. in Production Management. She also holds MSc from C
Nasdaq Nordic: Nasdaq Stockholm Welcomes Insplorion to the Nasdaq First North Growth Market
Stockholm, January 29, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in
Insplorion AB s shares (short name INSP) commences today on Nasdaq First North
Growth Market. The company belongs to the Technology sector. Insplorion is the
2nd company to be admitted to trading on Nasdaq s Nordic markets in 2021.
With its disrupting proprietary sensor platform, NanoPlasmonic Sensing (NPS),
Swedish company Insplorion currently have three main branches of operation.
Battery, air quality and hydrogen sensors, as well as NPS based research
equipment. NPS is a technology that makes it possible to study Nano processes
Nasdaq Nordic: Nasdaq Copenhagen welcomes Nexcom A/S to Nasdaq First North Growth Market Denmark
Copenhagen January 29, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in
the Nexom A/S share (short name: NEXCOM) starts today on Nasdaq First North
Growth Market Denmark. Nexcom belongs to the technology sector and is the 1st
company, which will be admitted to trading on Nasdaq Copenhagen in 2021 and is
no. 3 on the Nasdaq Nordic Market .
Nexcom A/S is a Software as a Service SaaS-based company that develops and
delivers software systems for automation and improvement of companies customer
service. Nexcom helps companies that have a large number of customers,
Share this article
STOCKHOLM, Jan. 29, 2021 /PRNewswire/
On November 16, 2020, OncoZenge AB (publ), Moberg Pharma s subsidiary, announced that the company had secured financing of a total of approximately SEK 70 million ahead of the spin-off and separate listing on Nasdaq First North Growth Market. Today, the Board of Moberg Pharma has decided that the record date for the right to receive shares in OncoZenge shall be February 5, 2021. The Board of OncoZenge has today, with the support of an authorization from an Extraordinary General Meeting on January 21, 2021, decided on the terms for the rights issue of approximately SEK 60 million (the Rights Issue ). In addition, an indicative timetable for both the Rights Issue and the listing process on Nasdaq First North Growth Market is announced, where the first day of trading is expected to be on February 12, 2021.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;